Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation-Reference-Cited by-同舟云学术

Complete Remission Status before Autologous Stem Cell Transplantation Is an Important Prognostic Factor in Patients with Multiple Myeloma Undergoing Upfront Single Autologous Transplantation

Published:2009-04 Issue:4 Volume:15 Page:463-470
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Kim Jin Seok,Kim Kihyun,Cheong June-Won,Min Yoo Hong,Suh Cheolwon,Kim Hawk,Jo Deog Yeon,Ryoo Hun Mo,Yoon Sung Soo,Lee Jae Hoon

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference23 articles.

1. Multiple myeloma;Kyle;N Engl J Med,2004

2. Recent major improvement in long-term survival of younger patients with multiple myeloma;Brenner;Blood,2008

3. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma;Barlogie;Blood,1997

4. Single versus double autologous stem-cell transplantation for multiple myeloma;Attal;N Engl J Med,2003

5. Cure of multiple myeloma: more hype, less reality;Hari;Bone Marrow Transplant,2006

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation;Cancer Science;2024-05-16

2. Comparison of tandem and single autologous stem cell transplantation in multiple myeloma: a retrospective propensity score-matching study;2024-04-18

3. Prognostic value of the “dynamic” second revision of the international staging system (R2- ISS) in patients with multiple myeloma undergoing anti-CD38 antibody, carfilzomib, and dexamethasone therapy;2024-03-21

4. Decreased circulating myeloid-derived suppressor cell count at the engraftment is one of the risk factors for multiple myeloma relapse after autologous hematopoietic stem cell transplantation;Heliyon;2024-03

5. The impact of daratumumab pretreatment on multiple myeloma patients undergoing autologous transplantation;2023-11-17